<DOC>
	<DOCNO>NCT00096746</DOCNO>
	<brief_summary>This study compare response subject fail first-line ATV-containing regimen 150L-containing virus subsequent protease inhibitor ( PI ) -containing therapy cohort fail first-line reverse transcriptase inhibitor ( NNRTI ) , subsequently receive PI-containing therapy .</brief_summary>
	<brief_title>Effect Atazanavir ( ATV ) 150L Mutation Subsequent Treatment Response HIV Infected Subjects</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<criteria>Currently firstline antiretroviral regimen contain ATV confirm rebound genotype verifies presence 150L mutation OR firstline regimen contain NNRTI PInaive , confirm rebound Women child bear potential unwilling unable use acceptable method avoid pregnancy entire study period 8 week study . Women pregnant breastfeeding . A life expectancy &lt; 12 month . Presence newly diagnose HIVrelated opportunistic infection medical condition require acute therapy time enrollment . Active alcohol substance abuse sufficient , investigator 's opinion , prevent adequate adherence study therapy increase risk develop pancreatitis chemical hepatitis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Treatment Experienced</keyword>
</DOC>